Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24e76490bed88751680a5fef9bc73892 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-40 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-00 |
filingDate |
2003-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0b2c2f03b886e3f10ac5954709e3009 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82bc34d14b765f4e44be30bc51e9ca9e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_212dc5c22f6294f662892f4cc108fb5e |
publicationDate |
2006-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
NZ-539849-A |
titleOfInvention |
Infant formula containing CMP, UMP, GMP, IMP and AMP |
abstract |
Disclosed is an infant formula composition for administration to preterm infant containing nucleotides in the following amounts: 3.2mg/L to 15.4 mg/L of CMP (cytidine monophosphate), 1.8 mg/L to 11.0 mg/L of UMP (uridine monophosphate), 1.8 mg/L to 8.0 mg/L of GMP (guanosine monophosphate), 0.1 mg/L to 2.2 mg/L of IMP (inosine monophosphate), 2.5mg/L to 13.2 mg/L of AMP (adenosine monophosphate). The above described formula may also be in the form of a concentrate liquid or powder which may be mixed with water to make a form for feeding. |
priorityDate |
2002-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |